FDA Outlines Plan for Expected $10M Under President’s Precision Medicine Plan

The FDA is planning to put the $10 million the agency expects to receive under the President’s Precision Medicine Initiative to set up databases that can help inform its oversight of next-generation sequencing tests, and to establish the bioinformatics infrastructure to facilitate the curation and sharing of the information in those repositories, an agency official said today. “Reliable and accurate next-gen sequencing technologies have a very large promise to accelerate personalized or precision medicine,” Elizabeth Mansfield, deputy office director for personalized medicine at FDA’s Center for Devices and Radiological Health, said during a briefing. “We here at the FDA are seriously committed to optimizing our regulatory oversight of this technology, [and] to ensure that the tests developed using it are not only safe and effective but are available for patient use as soon as possible.”

Source: https://www.genomeweb.com/regulatory-news/fda-outlines-plan-expected-10m-under-presidents-precision-medicine-plan?utm_source=SilverpopMailing&utm_medium=email&utm_campaign=Daily%20News%3A%20FDA%27s%20Plans%20for%20Expected%20Precision%20Medicine%20Funding%20-%2002/18/2015%2003%3A50%3A00%20PM